Seattle Treatment Education Project Img

Seattle Treatment Education Project

Who We Are

Originally established as an independent non-profit agency in 1989, the Seattle Treatment Education Project (STEP) has recently evolved into a program of Lifelong AIDS Alliance, a 501(c)(3) non-profit corporation. Located in Seattle, Washington, this group of men and women is dedicated to bringing treatment and prevention information to those infected with HIV or at risk of HIV infection, to health care providers and to members of HIV service organizations.

Our mission is to provide information, education and advocacy for individuals infected and affected by HIV/AIDS, their families, healthcare providers and entire communities. Our goal is to enable individuals to make informed healthcare decisions and to access options and devise strategies for their treatment.

Our Advisory Board members have backgrounds in various professional disciplines. The information we provide is not representative of any single treatment philosophy. Instead, STEP, as a program of Lifelong AIDS Alliance, endeavors to include HIV treatment information from all health care and service providers.

The STEP Program of Lifelong AIDS Alliance is non-partisan and not affiliated with any political or religious group. We seek to operate in cooperation with other HIV service organizations as part of a caring, supportive community.

Our programs are supported by individual contributions, but our services are provided to anyone free of charge. The STEP Program of Lifelong AIDS Alliance does not promote the philosophies or causes of contributors.

Our policies and official publications are the result of careful review and consensus of working Advisory Board members and supporting members. Our efforts represent the activities that members collectively feel will best provide objective information to those infected by HIV or at risk of HIV infection.

Latest by Seattle Treatment Education Project

Promo Image

Muscle-Wasting Effects of Low-Carb Diets on People With HIV

It is not hard to go into any grocery store these days and see at least one product that advertises low or no carbohydrates on the package. The world seems to have embraced the idea that no or low-carbohydrate diets are good for us. It is a common m...

By Shelley for Seattle Treatment Education Project
Promo Image
Health Coverage

Alphabet Soup: A Brief Guide to Washington State's Insurance Options

Medicare or Medicaid? EIP, EIIP, EHIP? COBRA? WSHIP? EOB's? CNP, MNP, QMB?

This flyer is meant to be a relatively short cheat-sheet to help keep these programs straight. We will not give all the details, but will summarize them and provide contact i...

By Ben Johnson for Seattle Treatment Education Project
Promo Image

Soap and Water: A Weapon Against HIV?

Editor's note: Soap and water will no doubt prove useful as a tool to reduce HIV transmission in developing countries where condoms are unavailable or negotiation for condom use is impossible. Soap and water is no substitute for proven safer sex meth...

By Janice Price for Seattle Treatment Education Project
Promo Image

More on Oral Sex and the Risk of HIV Transmission

In the following article and an article by Janice Price, we will entertain two different views on oral sex transmission of the HIV virus.

Detailed interviews of a cohort of gay men with acute infection provide further evidence that oral sex can be a...

By G. Sonia Nagy, M.D. for Seattle Treatment Education Project
Promo Image

What is CMV?

Cytomegalovirus (CMV) is a member of the herpes virus group, which includes the viruses that causes chicken pox, mononucleosis ("mono") and herpes simplexes 1 and 2. The viruses all share the ability to remain dormant in the body for a long time.


By Nancy Somes from the BABES Network for Seattle Treatment Education Project
Promo Image

Fuzeon (T-20), the First HIV Entry Inhibitor, Is Now FDA-Approved

The FDA approved licensing of Fuzeon on March 20, 2003. There remain, however, two major unanswered questions about this drug. The first is when Fuzeon should be used. The second is whether there are adequate supplies to meet the anticipated need for...

By Jeffrey T. Schouten, M.D. for Seattle Treatment Education Project
Promo Image

"TB" the Number One Killer of People With HIV

TB is an infection caused by a bacterium called Mycobacteria tuberculosis. It usually affects the lungs but can affect other organs also. TB is a very serious disease, it is estimated that one-third of the people in the world are infected with TB. Te...

By Erica Rocker, Treatment Educator BABES Network for Seattle Treatment Education Project
Promo Image

HIV in Women

A stereotype exists in the United States that AIDS is a gay disease. Although AIDS was first documented among homosexual men is this country in 1981, according to the U.S. Centers for Disease Control (CDC), the total AIDS cases attributable to wome...

By Deb Goldman, A.R.N.P., Northwest Family Center for Seattle Treatment Education Project
Promo Image

Therapeutic Drug Monitoring: The Next Best Thing in HIV Treatment?

Therapeutic drug monitoring (TDM) uses blood levels of a drug to adjust its dose to achieve the maximal benefit and/or to achieve the minimal toxicity. This approach to customizing drug dosing has great appeal for the treatment of HIV. The promise of...

By Jeffrey T. Schouten, M.D. and Rolf Christensen, D.D.S. for Seattle Treatment Education Project
Promo Image

Challenges in Prevention: Should STD and HIV Prevention Be Integrated?

Last week marked the sixth year since the Institute of Medicine, in its landmark report, "The Hidden Epidemic: Confronting Sexually Transmitted Diseases," challenged the sexually transmitted disease (STD) prevention community and its multiple partner...

By Seattle Treatment Education Project